Octagon Capital Advisors »

Female Health shares owned by Octagon Capital Advisors

Quarter-by-quarter ownership of Female Health (VERU) shares owned by Octagon Capital Advisors from 13F filings

Historical chart of Octagon Capital Advisors investment in Female Health

Tip: Access up to 7 years of quarterly data

All positions including Female Health held by Octagon Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Female Health by Octagon Capital Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.7M 3.8M 0.72

More positions owned by Octagon Capital Advisors

Apellis Pharmaceuticals (APLS)
Cymabay Therapeutics
Verona Pharma Sponsored Ads (VRNA)
Insmed Com Par $.01 (INSM)
Arcus Biosciences Incorporated (RCUS)
Bridgebio Pharma (BBIO)
Celldex Therapeutics Com New (CLDX)
Roivant Sciences SHS (ROIV)
Alpine Immune Sciences (ALPN)
Structure Therapeutics Sponsored Ads (GPCR)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
An2 Therapeutics (ANTX)
Miragen Therapeutics (VRDN)
Immunovant (IMVT)
Dyne Therapeutics (DYN)

View all positions for Octagon Capital Advisors

Top funds holding Female Health

Perceptive Advisors
Vanguard Group
Rosalind Advisors
Octagon Capital Advisors
AIGH Capital Management
AWM Investment Company
Maven Securities
Henderson Group
Laurion Capital Management
J. Goldman & Co
Worth Venture Partners
Alyeska Investment Group
Potomac Capital Management
Alpine Partners VI
ADAR1 Capital Management

View all funds holding Female Health